
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
K. A. Jellinger, Amos D. Korczyn
BMC Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 320
K. A. Jellinger, Amos D. Korczyn
BMC Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 320
Showing 1-25 of 320 citing articles:
Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes
Sarah H. Shahmoradian, Amanda J. Lewis, Christel Genoud, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 7, pp. 1099-1109
Closed Access | Times Cited: 790
Sarah H. Shahmoradian, Amanda J. Lewis, Christel Genoud, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 7, pp. 1099-1109
Closed Access | Times Cited: 790
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
Michaël E. Belloy, Valerio Napolioni, Michael D. Greicius
Neuron (2019) Vol. 101, Iss. 5, pp. 820-838
Open Access | Times Cited: 435
Michaël E. Belloy, Valerio Napolioni, Michael D. Greicius
Neuron (2019) Vol. 101, Iss. 5, pp. 820-838
Open Access | Times Cited: 435
Genetics of Parkinson's disease: An introspection of its journey towards precision medicine
Sara Bandrés‐Ciga, Mónica Díez-Fairén, Jonggeol Jeff Kim, et al.
Neurobiology of Disease (2020) Vol. 137, pp. 104782-104782
Open Access | Times Cited: 306
Sara Bandrés‐Ciga, Mónica Díez-Fairén, Jonggeol Jeff Kim, et al.
Neurobiology of Disease (2020) Vol. 137, pp. 104782-104782
Open Access | Times Cited: 306
Dementia with Lewy bodies: an update and outlook
Tiago F. Outeiro, David J. Koss, Daniel Erskine, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 295
Tiago F. Outeiro, David J. Koss, Daniel Erskine, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 295
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
K. A. Jellinger
Journal of Neural Transmission (2017) Vol. 125, Iss. 4, pp. 615-650
Closed Access | Times Cited: 230
K. A. Jellinger
Journal of Neural Transmission (2017) Vol. 125, Iss. 4, pp. 615-650
Closed Access | Times Cited: 230
Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
Masaru Tanaka, József Toldi, László Vécsei
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2431-2431
Open Access | Times Cited: 211
Masaru Tanaka, József Toldi, László Vécsei
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2431-2431
Open Access | Times Cited: 211
Is Alzheimer disease a disease?
Amos D. Korczyn, Lea T. Grinberg
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 245-251
Closed Access | Times Cited: 57
Amos D. Korczyn, Lea T. Grinberg
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 245-251
Closed Access | Times Cited: 57
Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune
Samuel M. Goldman, Frances M. Weaver, Kevin T. Stroupe, et al.
JAMA Neurology (2023) Vol. 80, Iss. 7, pp. 673-673
Closed Access | Times Cited: 46
Samuel M. Goldman, Frances M. Weaver, Kevin T. Stroupe, et al.
JAMA Neurology (2023) Vol. 80, Iss. 7, pp. 673-673
Closed Access | Times Cited: 46
Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same
Per Borghammer, Niels Okkels, Daniel Weintraub
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 383-397
Open Access | Times Cited: 15
Per Borghammer, Niels Okkels, Daniel Weintraub
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 383-397
Open Access | Times Cited: 15
The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Daniel Weintraub, Eugenia Mamikonyan
American Journal of Geriatric Psychiatry (2019) Vol. 27, Iss. 9, pp. 998-1018
Open Access | Times Cited: 129
Daniel Weintraub, Eugenia Mamikonyan
American Journal of Geriatric Psychiatry (2019) Vol. 27, Iss. 9, pp. 998-1018
Open Access | Times Cited: 129
Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer’s disease, Parkinson’s disease
Sean Hong Tan, Venkatanaidu Karri, Nicole Wuen Rong Tay, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 765-777
Open Access | Times Cited: 119
Sean Hong Tan, Venkatanaidu Karri, Nicole Wuen Rong Tay, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 765-777
Open Access | Times Cited: 119
Alzheimer’s Disease and Parkinson’s Disease: A Nutritional Toxicology Perspective of the Impact of Oxidative Stress, Mitochondrial Dysfunction, Nutrigenomics and Environmental Chemicals
Aayushi Agnihotri, Okezie I. Aruoma
Journal of the American College of Nutrition (2019) Vol. 39, Iss. 1, pp. 16-27
Open Access | Times Cited: 116
Aayushi Agnihotri, Okezie I. Aruoma
Journal of the American College of Nutrition (2019) Vol. 39, Iss. 1, pp. 16-27
Open Access | Times Cited: 116
Cell-to-Cell Transmission of Tau and α-Synuclein
Norihito Uemura, Maiko Uemura, Kelvin C. Luk, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 10, pp. 936-952
Open Access | Times Cited: 116
Norihito Uemura, Maiko Uemura, Kelvin C. Luk, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 10, pp. 936-952
Open Access | Times Cited: 116
Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes
Usman Saeed, Anthony E. Lang, Mario Masellis
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 110
Usman Saeed, Anthony E. Lang, Mario Masellis
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 110
Seeding variability of different alpha synuclein strains in synucleinopathies
Niccolò Candelise, Matthias Schmitz, Franc Llorens, et al.
Annals of Neurology (2019) Vol. 85, Iss. 5, pp. 691-703
Closed Access | Times Cited: 98
Niccolò Candelise, Matthias Schmitz, Franc Llorens, et al.
Annals of Neurology (2019) Vol. 85, Iss. 5, pp. 691-703
Closed Access | Times Cited: 98
Amyloid-β and Parkinson’s disease
Ee Wei Lim, Dag Aarsland, Dominic ffytche, et al.
Journal of Neurology (2018) Vol. 266, Iss. 11, pp. 2605-2619
Closed Access | Times Cited: 97
Ee Wei Lim, Dag Aarsland, Dominic ffytche, et al.
Journal of Neurology (2018) Vol. 266, Iss. 11, pp. 2605-2619
Closed Access | Times Cited: 97
Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports
Hilal A. Lashuel
Neurobiology of Disease (2020) Vol. 141, pp. 104876-104876
Open Access | Times Cited: 96
Hilal A. Lashuel
Neurobiology of Disease (2020) Vol. 141, pp. 104876-104876
Open Access | Times Cited: 96
Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme
Michael L. Alosco, Jonathan D. Cherry, Bertrand R. Huber, et al.
Acta Neuropathologica (2020) Vol. 140, Iss. 4, pp. 495-512
Open Access | Times Cited: 89
Michael L. Alosco, Jonathan D. Cherry, Bertrand R. Huber, et al.
Acta Neuropathologica (2020) Vol. 140, Iss. 4, pp. 495-512
Open Access | Times Cited: 89
Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework
Elie Matar, James M. Shine, Glenda M. Halliday, et al.
Brain (2019) Vol. 143, Iss. 1, pp. 31-46
Open Access | Times Cited: 80
Elie Matar, James M. Shine, Glenda M. Halliday, et al.
Brain (2019) Vol. 143, Iss. 1, pp. 31-46
Open Access | Times Cited: 80
Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases
David G. Coughlin, Howard I. Hurtig, David J. Irwin
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 5-19
Open Access | Times Cited: 79
David G. Coughlin, Howard I. Hurtig, David J. Irwin
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 5-19
Open Access | Times Cited: 79
Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease
Joseph Blommer, Toni L. Pitcher, Maja Mustapić, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 195-208
Open Access | Times Cited: 63
Joseph Blommer, Toni L. Pitcher, Maja Mustapić, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 195-208
Open Access | Times Cited: 63
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
Nelson de Oliveira Manzanza, Lucia Sedlackova, Raj N. Kalaria
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 57
Nelson de Oliveira Manzanza, Lucia Sedlackova, Raj N. Kalaria
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 57
Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
Marc Cárceles-Cordon, Dan Weintraub, Alice Chen‐Plotkin
Neuron (2023) Vol. 111, Iss. 10, pp. 1531-1546
Open Access | Times Cited: 26
Marc Cárceles-Cordon, Dan Weintraub, Alice Chen‐Plotkin
Neuron (2023) Vol. 111, Iss. 10, pp. 1531-1546
Open Access | Times Cited: 26
Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders
Celtia Domínguez-Fernández, June Egiguren-Ortiz, Jone Razquin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3321-3321
Open Access | Times Cited: 23
Celtia Domínguez-Fernández, June Egiguren-Ortiz, Jone Razquin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3321-3321
Open Access | Times Cited: 23
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
Sophie E Mastenbroek, Jacob W. Vogel, Lyduine E. Collij, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Sophie E Mastenbroek, Jacob W. Vogel, Lyduine E. Collij, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13